158 related articles for article (PubMed ID: 34011343)
1. Lymphoproliferative malignancies in patients with neurofibromatosis 1.
Bergqvist C; Hemery F; Jannic A; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2021 May; 16(1):230. PubMed ID: 34011343
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system lymphoma occurring in a patient with neurofibromatosis type 1 (von Recklinghausen disease).
Eoli M; Bianchessi D; Di Stefano AL; Prodi E; Anghileri E; Finocchiaro G
Neurol Sci; 2012 Dec; 33(6):1429-33. PubMed ID: 22294052
[TBL] [Abstract][Full Text] [Related]
5. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
8. Oncologic manifestations in children with neurofibromatosis type 1 in Turkey.
İncecik F; Altunbaşak Ş; Hergüner MÖ; Bayram İ; Küpeli S; Demirbilek H
Turk J Pediatr; 2013; 55(3):266-70. PubMed ID: 24217072
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
10. In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study.
Diaz E; Bergqvist C; Peiffer B; Fertitta L; Jannic A; Ferkal S; Zehou O; Hemery F; Sbidian E; Wolkenstein P
J Invest Dermatol; 2023 Dec; 143(12):2408-2415.e7. PubMed ID: 37257636
[TBL] [Abstract][Full Text] [Related]
11. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 and childhood cancer.
Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
[TBL] [Abstract][Full Text] [Related]
13. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
14. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
15. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis Type I and Hodgkin Lymphoma: Case Report and Review of the Literature.
Yıldırım ÜM; Kebudi R
Turk Arch Pediatr; 2022 Sep; 57(5):566-568. PubMed ID: 36062445
[TBL] [Abstract][Full Text] [Related]
17. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis.
Lee TJ; Chopra M; Kim RH; Parkin PC; Barnett-Tapia C
Orphanet J Rare Dis; 2023 Sep; 18(1):292. PubMed ID: 37710322
[TBL] [Abstract][Full Text] [Related]
19. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
Orphanet J Rare Dis; 2018 Jan; 13(1):5. PubMed ID: 29335026
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neuroradiological characterisation of spinal lesions in adults with Neurofibromatosis type 1.
Curtis-Lopez CM; Soh C; Ealing J; Gareth Evans D; Burkitt Wright EMM; Vassallo G; Karabatsou K; Joshi George K
J Clin Neurosci; 2020 Jul; 77():98-105. PubMed ID: 32417129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
